Cell and Gene Therapy
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31